Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...
Medpage Today on MSN1d
Will Trump Adopt the Current FTC's Antitrust Posture?The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...
What started off as a dice roll of a new practice group at Russ August & Kabat has turned into the breadwinner of the ...
Technology company Adeia claimed Disney+, ESPN+ and Hulu all infringed on patent-protected technology ... launching after ...
Xockets fell victim to Big Tech’s predatory infringement when Nvidia and Microsoft adopted its DPU technology to enable AI ...
In the immediate wake of such an historic election, it is far too early to know what the intellectual property landscape will ...
Teva’s Inhaler Patents relate generally to an inhaler ... This is because Amneal’s counterclaims are not an expansion of antitrust law, the FDA does not directly police the Orange Book ...
The European Commission has hit the world's largest maker of generic drugs with a €462.6 million fine for breaching the ...
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...
On October 31, 2024, the European Commission (EC) fined Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Europe BV (Teva) ...
In the early to mid-2000s, Yahoo! worked to develop and refine its search engine capabilities. During this period, Yahoo! obtained U.S. Patent Nos. 8,341,157, 7,698,329, 8,209,317, 9,805,097, and ...
The National Law Review is not a law firm nor is www.NatLawReview.com intended to be a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback